Endourological Management of Stones During COVID19

• Sponsor: Roxanne Teo (Other)
• Overall Status: Completed
• CT.gov ID: NCT05293262
• Collaborator: (none)
• Enrollment: 158
• Location: 1
• Actual Duration (Months): 7.3
• Patients Per Site Per Month: 21.8

Study Details

Study Description

Brief Summary

Guidelines for endourological procedures during COVID-19 have suggested deferring all elective procedures, while obstructed/ infected stones should undergo urgent decompression.

At our centre, screening protocols were implemented with prioritization strategies so that elective care could safely continue at deescalated rates. COVID or septic patients underwent emergency decompression, while non-COVID and non-septic patients underwent primary ureteroscopy (URS) or retrograde intrarenal surgery (RIRS).

We aim to report our experience with endourological surgery for stone disease during COVID-19.

Condition or Disease	Intervention/Treatment	Phase
Urolithiasis; COVID-19	Procedure: Endourological surgery

Detailed Description

We conducted a retrospective review of a prospectively maintained database of all endourological surgeries for stones in our centre during the first wave of COVID19.

Study Design

• Study Type: Observational
• Actual Enrollment: 158 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Official Title: Definitive Endourological Interventions for Urolithiasis Management During COVID19- Outcomes From a Cohort Study
• Actual Study Start Date: Jan 23, 2020
• Actual Primary Completion Date: Aug 31, 2020
• Actual Study Completion Date: Aug 31, 2020

Arms and Interventions

Arm	Intervention/Treatment
Patients who underwent endourological surgery for urolithiasis during COVID19 Endourological surgery (including ureteral stent insertion, ureteroscopy, retrograde intrarenal surgery)	Procedure: Endourological surgery; Includes ureteral stent insertion, ureteroscopies and retrograde intrarenal surgeies

Outcome Measures

Primary Outcome Measures

1. Length of hospital stay [From admission to discharge from hospital, up to 3 months]

   Length of hospital stay

2. Complication rate [From admission up to 3 months post operatively]

   Complications as defined by Clavien Dindo classification system

3. Stone free rate [At follow up visit in clinic 3 months post procedure]

Secondary Outcome Measures

1. Readmission rate [From discharge up to three months post operatively]

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion criteria

• all patient with urolithiasis who underwent endourological interventions during COVID19 pandemic

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Ng Teng Fong General Hospital, Singapore	Singapore		Singapore	609606

Sponsors and Collaborators

• Roxanne Teo

Investigators

• Principal Investigator: Chin Tiong Heng, Ng Teng Fong General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Roxanne Teo, Medical Officer, National University Health System, Singapore
• ClinicalTrials.gov Identifier: NCT05293262
• Other Study ID Numbers: 2020/01298
• First Posted: Mar 24, 2022
• Last Update Posted: Mar 24, 2022
• Last Verified: Mar 1, 2022

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Roxanne Teo, Medical Officer, National University Health System, Singapore: endourology; pandemic
• Additional relevant MeSH terms: COVID-19; Urolithiasis; Urinary Calculi

Study Results

No Results Posted as of Mar 24, 2022